查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1768183

全球醫療保健人工智慧（AI）市場

Artificial Intelligence (AI) in Healthcare
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年，全球醫療保健人工智慧 (AI) 市場規模將達到 3,465 億美元

2024年，全球醫療保健領域人工智慧 (AI) 市場規模估計為551億美元，預計到2030年將達到3,465億美元，2024年至2030年期間的複合年成長率為35.8%。軟體是本報告分析的細分市場之一，預計其複合年成長率為37.1%，到分析期結束時將達到1772億美元。硬體細分市場在分析期間內的複合年成長率估計為35.4%。

美國市場規模估計為 167 億美元，中國市場預計複合年成長率為 34.1%

美國醫療保健領域的人工智慧 (AI) 市場規模預計在 2024 年達到 167 億美元。預計到 2030 年，作為世界第二大經濟體的中國市場規模將達到 498 億美元，在 2024-2030 年的分析期內，複合年成長率將達到 34.1%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為 32.0% 和 30.1%。在歐洲，預計德國市場的複合年成長率約為 24.6%。

全球醫療保健市場人工智慧（AI）—主要趨勢和促進因素摘要

人工智慧如何提高診斷準確性和患者治療效果？

人工智慧 (AI) 正在改變醫療保健領域的診斷方式，使其能夠更快、更準確地進行評估，從而對患者的預後產生重大影響。傳統上，診斷在很大程度上依賴臨床醫生的專業知識和經驗，但現在，AI 透過快速分析醫療數據和影像來增強診斷過程，從而提高準確性並減少人為錯誤的可能性。例如，放射學中的機器學習演算法可以透過即時掃描影像資料來檢測癌症、肺炎和心血管疾病等疾病的早期跡象，通常可以在症狀出現之前就發現問題。 Zebra Medical Vision 和 Aidoc 等公司正在利用深度學習以驚人的準確性解讀電腦斷層掃描、MRI 和 X 光片，幫助放射科醫生更快地做出明智的決策。此外，AI 模型透過分析電子健康記錄(EHR)、檢測結果和基因訊息，為醫生提供切實可行的見解，以預測患者風險並追蹤病情進展。透過實現更快的診斷和更個人化的治療方案，AI主導的診斷技術正在改善患者預後、縮短住院時間，並為更積極主動的醫療保健方法鋪平道路。

人工智慧可以改變個人化醫療和藥物發現嗎？

人工智慧在個人化治療和加速藥物研發方面的潛力正在重新定義全球產業分析師的患者照護方式。精準醫療是一個快速發展的領域，它利用人工智慧根據個人的基因組成、生活方式和特定健康狀況量身定做治療方案。透過分析包含遺傳資訊、生活方式因素和既往健康記錄的複雜資料集，人工智慧演算法可以提案高度個人化的治療方案，以最佳化治療效果並減少副作用。例如，IBM 的 Watson for Oncology 使用人工智慧根據個別患者數據和海量醫學文獻庫提案癌症治療方案，幫助腫瘤學家做出明智的決策。在藥物研發領域，人工智慧可以加速潛在候選藥物的識別，預測不同分子之間的相互作用，甚至識別可能的副作用，從而減少傳統藥物研發所需的時間和成本。 Atomwise 和 BenevolentAI 等人工智慧平台使用深度學習模型分析分子結構，從而加快了曾經耗時數年的研究過程。透過增強個人化醫療並加速藥物研發，人工智慧正在徹底改變治療方法的開發和交付方式，最終透過更有效、更及時的醫療保健解決方案使患者受益。

人工智慧如何幫助提高醫療保健領域的業務效率和資源管理？

人工智慧推動了醫療保健領域業務效率和資源管理的顯著進步，解決了人員短缺、資源分配和患者等待時間等長期存在的問題。醫院和醫療服務提供者正在利用人工智慧預測分析技術進行排班、人員編制和病患流量管理，以最佳化這些流程，消除過度擁擠並確保資源的有效利用。例如，演算法可以預測急診和診所的高峰時間，從而更好地準備和調整人員，從而最大限度地減少患者等待時間。此外，電子病歷 (EHR) 管理中的人工智慧可以自動執行重複的管理業務，例如資料輸入、索賠處理和開立發票，從而減輕了醫護人員的管理負擔並提高了整體效率。虛擬助理和聊天機器人進一步減輕了營運負擔，例如回覆患者問詢、安排預約和提醒患者服藥，從而在不給醫務人員帶來壓力的情況下提高了業務品質。透過簡化業務，人工智慧使醫療服務提供者能夠更加專注於直接的患者護理，提高效率並將資源分配到最需要的地方。

哪些因素將推動醫療保健領域人工智慧的發展？

醫療保健領域人工智慧市場的成長受到多種關鍵因素的推動，例如技術進步和不斷發展的醫療保健需求加速了人工智慧的應用。醫學影像、基因圖譜和穿戴式醫療設備產生的醫療保健資料量不斷成長，催生了對能夠解讀這些大量資料集的人工智慧主導分析的需求。消費者對個人化和主動性醫療保健服務的需求是主要促進因素，因為患者越來越期望獲得量身定做的治療方案和預防性護理方案。自然語言處理和電腦視覺技術的進步增強了人工智慧解讀醫療數據和基於語言的健康資訊的能力，使其成為診斷、病患監測和個人化醫療的關鍵。此外，全球正轉向基於價值的醫療服務，這種醫療服務強調基於結果的治療而非基於數量的服務，這與人工智慧在提高診斷準確性、最佳化治療方案和預測患者結果方面的能力密切相關。慢性病的增加進一步增加了對患者監測和管理方面人工智慧解決方案的需求。政府措施和私人對醫療保健技術的投資正在加速該領域的研發，刺激創新並擴大人工智慧在醫療保健領域的應用。這是為了滿足消費者的需求以及行業向數據驅動、高效和以患者為中心的護理的轉變。

部分

組件（軟體、硬體、服務）、技術（機器學習、自然語言處理、情境感知計算、電腦視覺）、應用（臨床試驗、機器人輔助手術、連網機器、詐騙偵測、診斷、虛擬助理、減少用藥錯誤、其他應用）、最終用途（醫院和醫療保健提供者、患者、製藥和生物技術公司、醫療保健付款人、其他最終用途）

受訪公司範例

  • Amazon Web Services（Aws）
  • Enlitic Inc.
  • General Electric Company
  • General Vision
  • Google
  • IBM Corporation
  • iCarbonX
  • Intel Corporation
  • Johnson & Johnson Services
  • Koninklijke Philips
  • Medtronic
  • Micron Technology
  • Microsoft Corporation
  • Next IT Corp.
  • Nvidia Corporation
  • Siemens Healthineers（A Strategic Unit Of Siemens Group）
  • Welltok Inc.

人工智慧整合

全球產業分析師正在利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 並未遵循典型的 LLM 或特定產業的 SLM查詢，而是建立了一個從全球專家收集的內容庫，其中包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 比賽

簡介目錄
Product Code: MCP21181

Global Artificial Intelligence (AI) in Healthcare Market to Reach US$346.5 Billion by 2030

The global market for Artificial Intelligence (AI) in Healthcare estimated at US$55.1 Billion in the year 2024, is expected to reach US$346.5 Billion by 2030, growing at a CAGR of 35.8% over the analysis period 2024-2030. Software, one of the segments analyzed in the report, is expected to record a 37.1% CAGR and reach US$177.2 Billion by the end of the analysis period. Growth in the Hardware segment is estimated at 35.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$16.7 Billion While China is Forecast to Grow at 34.1% CAGR

The Artificial Intelligence (AI) in Healthcare market in the U.S. is estimated at US$16.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$49.8 Billion by the year 2030 trailing a CAGR of 34.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 32.0% and 30.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 24.6% CAGR.

Global Artificial Intelligence (AI) in Healthcare Market - Key Trends and Drivers Summarized

How Is AI Enhancing Diagnostic Accuracy and Patient Outcomes?

Artificial Intelligence (AI) is transforming diagnostics in healthcare, enabling faster, more accurate assessments that significantly impact patient outcomes. Traditionally, diagnoses relied heavily on a clinician’s expertise and experience, but AI now augments this process by rapidly analyzing medical data and imaging with a level of precision that reduces the likelihood of human error. Machine learning algorithms in radiology, for example, can detect early signs of diseases like cancer, pneumonia, and cardiovascular disorders by scanning imaging data in real time, often identifying issues before symptoms manifest. Companies like Zebra Medical Vision and Aidoc are employing deep learning to interpret CT scans, MRIs, and X-rays with remarkable accuracy, assisting radiologists in making informed decisions quickly. Furthermore, AI models predict patient risks and track disease progression by analyzing electronic health records (EHRs), laboratory results, and genetic information, providing doctors with actionable insights. By enabling faster diagnoses and more personalized treatment plans, AI-driven diagnostics are improving patient outcomes, reducing hospital stays, and paving the way for a more proactive healthcare approach.

Can AI Transform Personalized Treatment and Drug Discovery?

AI’s potential to individualize treatments and expedite drug discovery is redefining how we approach patient care. Precision medicine, a rapidly growing field, leverages AI to customize treatment plans tailored to an individual’s unique genetic makeup, lifestyle, and specific health conditions. By analyzing complex datasets that include genetic information, lifestyle factors, and previous health records, AI algorithms can suggest highly personalized therapies, optimizing treatment efficacy and reducing adverse reactions. IBM’s Watson for Oncology, for instance, uses AI to recommend cancer treatment options based on individual patient data and an extensive library of medical literature, supporting oncologists in making well-informed decisions. In drug discovery, AI accelerates the identification of potential drug candidates, predicting how different molecules might interact and even identifying possible side effects, reducing the time and costs associated with traditional drug development. AI platforms like Atomwise and BenevolentAI use deep learning models to analyze molecular structures, expediting the research process that once took years. By enhancing personalized care and fast-tracking drug discovery, AI is revolutionizing how treatments are developed and delivered, ultimately benefiting patients through more effective and timely medical solutions.

How Is AI Assisting in Operational Efficiency and Resource Management in Healthcare?

AI is driving significant advancements in operational efficiency and resource management within the healthcare sector, addressing longstanding issues like staff shortages, resource allocation, and patient wait times. Hospitals and healthcare providers are utilizing AI-driven predictive analytics to manage scheduling, staff allocation, and patient flow, optimizing these processes to reduce overcrowding and ensure that resources are used efficiently. For example, algorithms can predict peak times in emergency departments or clinics, allowing for better preparation and staffing adjustments, thereby minimizing patient wait times. Additionally, AI in EHR management automates repetitive administrative tasks such as data entry, claims processing, and billing, reducing the administrative burden on healthcare staff and improving overall efficiency. Virtual health assistants and chatbots are further alleviating workload by addressing patient queries, scheduling appointments, and reminding patients of medication, enhancing service quality without overwhelming healthcare personnel. By streamlining operations, AI enables healthcare providers to focus more on direct patient care, increasing efficiency and ensuring resources are deployed where they are most needed.

What Factors Are Driving the Growth of AI in the Healthcare Market?

The growth in the AI in healthcare market is driven by several key factors, as advancements in technology and evolving healthcare needs accelerate AI adoption. Increasing healthcare data volumes, generated from medical imaging, genetic profiles, and wearable health devices, necessitate AI-driven analytics capable of making sense of these massive datasets. Consumer demand for personalized and proactive healthcare services is a primary driver, as patients increasingly expect tailored treatment plans and preventive care options. Technological advancements in natural language processing and computer vision are enhancing AI’s capabilities in interpreting medical data and language-based health information, making AI indispensable for diagnostics, patient monitoring, and personalized medicine. Additionally, the global shift toward value-based care, which emphasizes outcome-driven treatments over volume-based services, aligns closely with AI’s ability to improve diagnostic accuracy, optimize treatment plans, and predict patient outcomes. The rising prevalence of chronic diseases has further increased the need for AI solutions in patient monitoring and management. Government initiatives and private-sector investments in health technology are accelerating research and development in this area, encouraging innovation and expanding AI applications in healthcare. Together, these drivers indicate a transformative period for AI in healthcare, as it responds to both consumer demands and the industry’s shift towards data-centric, efficient, and patient-focused care.

SCOPE OF STUDY:

The report analyzes the Artificial Intelligence (AI) in Healthcare market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Software, Hardware, Services); Technology (Machine Learning, Natural Language Processing, Context-Aware Computing, Computer Vision); Application (Clinical Trials, Robot-Assisted Surgery, Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications); End-Use (Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 222 Featured) -

  • Amazon Web Services (Aws)
  • Enlitic Inc.
  • General Electric Company
  • General Vision
  • Google
  • IBM Corporation
  • iCarbonX
  • Intel Corporation
  • Johnson & Johnson Services
  • Koninklijke Philips
  • Medtronic
  • Micron Technology
  • Microsoft Corporation
  • Next IT Corp.
  • Nvidia Corporation
  • Siemens Healthineers (A Strategic Unit Of Siemens Group)
  • Welltok Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Artificial Intelligence (AI) in Healthcare - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Personalized Patient Care Propels Growth of AI in Healthcare
    • Focus on Early Disease Detection and Prevention Drives Adoption of AI-Powered Diagnostic Tools
    • Here's How Predictive Analytics in AI Enhances Patient Care Pathways and Outcome Optimization
    • Advances in Medical Imaging and Computer Vision Boost Precision in AI-Driven Diagnostic Solutions
    • Rising Prevalence of Chronic Diseases Expands Market for AI-Powered Remote Monitoring Systems
    • Here's How Natural Language Processing in AI Improves Medical Record Analysis and Documentation
    • Increasing Utilization of AI for Accelerating Drug Discovery and Development Processes
    • Focus on Enhancing Resource Allocation Drives AI Adoption in Healthcare Workforce Management
    • Growing Demand for Telemedicine Expands the Scope of AI in Remote Patient Monitoring
    • Here's How AI in Genomics Supports Personalized Treatment Plans and Precision Medicine Initiatives
    • Advancements in AI-Driven Robotics Transform Surgical and Rehabilitation Practices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 4: World 6-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World 6-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Healthcare Payers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World 6-Year Perspective for Healthcare Payers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 10: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals & Healthcare Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World 6-Year Perspective for Hospitals & Healthcare Providers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World 6-Year Perspective for Patients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Pharmaceuticals & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 16: World 6-Year Perspective for Pharmaceuticals & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Machine Learning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World 6-Year Perspective for Machine Learning by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Natural Language Processing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World 6-Year Perspective for Natural Language Processing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 21: World Recent Past, Current & Future Analysis for Context-Aware Computing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 22: World 6-Year Perspective for Context-Aware Computing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Computer Vision by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World 6-Year Perspective for Computer Vision by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 25: World Artificial Intelligence (AI) in Healthcare Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Connected Machines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Connected Machines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Fraud Detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Fraud Detection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World 6-Year Perspective for Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Virtual Assistants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 35: World 6-Year Perspective for Virtual Assistants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 36: World Recent Past, Current & Future Analysis for Dosage Error Reduction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 37: World 6-Year Perspective for Dosage Error Reduction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 40: World Recent Past, Current & Future Analysis for Clinical Trials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 41: World 6-Year Perspective for Clinical Trials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 42: World Recent Past, Current & Future Analysis for Robot-Assisted Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 43: World 6-Year Perspective for Robot-Assisted Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 46: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: USA 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 48: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: USA 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • CANADA
    • TABLE 52: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Canada 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 54: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Canada 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 58: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Canada 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • JAPAN
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 60: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Japan 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 64: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Japan 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 66: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Japan 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • CHINA
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 70: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: China 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 72: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: China 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • EUROPE
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 76: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 77: Europe 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 78: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Europe 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 82: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Europe 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 84: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Europe 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • FRANCE
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 88: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: France 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 90: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: France 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • GERMANY
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 94: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Germany 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 96: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Germany 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 100: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Germany 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • ITALY
    • TABLE 102: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Italy 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 106: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Italy 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 108: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Italy 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 112: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 113: UK 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 114: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 115: UK 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 118: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Rest of Europe 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 120: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Rest of Europe 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 124: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of Europe 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 126: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Asia-Pacific 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 130: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Asia-Pacific 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 132: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Asia-Pacific 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of World 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 136: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 137: Rest of World 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 138: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 139: Rest of World 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030

IV. COMPETITION